-
1
Diffuse large B‐cell lymphoma presenting with pulmonary artery compression symptoms, case reports
Published 2024“…<p dir="ltr">Mediastinal diffuse large B‐cell lymphoma (DLBC) may manifest in different presentations including systemic symptoms and local mass symptoms. …”
-
2
Benefit of consolidative radiation therapy in patients with diffuse large B-cell lymphoma treated with R-CHOP chemotherapy
Published 2010“…Purpose The current standard therapy for patients with diffuse large B-cell lymphoma (DLBCL) is rituximab plus cyclophosphamide, doxorubicin, vincristine, and prednisone (R-CHOP). …”
Get full text
Get full text
article -
3
Proteomic Profiling of Small-Cell Lung Cancer: A Systematic Review
Published 2023“…Additionally, the study identifies proteins differentially expressed between SCLC and large cell neuroendocrine carcinoma (LCNEC), aiming to discover biomarkers distinguishing between these two subtypes of neuroendocrine lung cancers. …”
-
4
The microbiome-lymphoma Axis: A systematic review and Meta-analysis of gut Dysbiosis pattern in diffuse large B-cell lymphoma
Published 2025“…Increasing evidence suggests that gut dysbiosis may play a significant role in the pathogenesis of diffuse large B-cell lymphoma (DLBCL), the most common and aggressive subtype of non-Hodgkin lymphoma (NHL). …”
-
5
-
6
-
7
Columnar cell lesions
Published 2004“…Within this large category, a group of lesions having in common a population of atypical cells (frequently columnar shaped) is emerging as early neoplastic lesions. …”
Get full text
Get full text
Get full text
Get full text
article -
8
-
9
Morphological changes in amblyopic eyes in choriocapillaris and Sattler’s layer in comparison to healthy eyes, and in retinal nerve fiber layer in comparison to fellow eyes through...
Published 2021“…Results The method of measuring reflectivity is good to excellent reliability for all regions of interest except the fourth. The mean reflectivity of the choriocapillaris and Sattler’s layer in amblyopic eyes were significantly lower than in healthy eyes (p = 0.003 and p = 0.008 respectively). …”
Get full text
Get full text
Get full text
Get full text
article -
10
Targeting of lactate dehydrogenase C dysregulates the cell cycle and sensitizes breast cancer cells to DNA damage response targeted therapy
Published 2021“…Silencing LDHC in four breast cancer cell lines significantly increased the presence of giant cells, nuclear aberrations, DNA damage, and apoptosis. …”
-
11
Evidence and gaps in clinical outcomes of novel pharmacologic therapies for sickle cell disease: A systematic literature review highlighting insights from clinical trials and real-...
Published 2025“…The high discontinuation rate and results of the STAND trial led to a significant decrease in the use of crizanlizumab. The HOPE trial demonstrated a 51 % improvement in hemoglobin response and a reduction in hemolytic markers in patients treated with voxelotor. …”
-
12
Dysregulated FOXM1 signaling in the regulation of cancer stem cells
Published 2022“…<p>Since the introduction of the cancer stem cell (CSC) paradigm, significant advances have been made in understanding the functional and biological plasticity of these elusive components in malignancies. …”
-
13
Antioxidant Activity Mediates Pirfenidone Antifibrotic Effects in Human Pulmonary Vascular Smooth Muscle Cells Exposed to Sera of Idiopathic Pulmonary Fibrosis Patients
Published 2018“…Here, we demonstrated for the first time that an increase of reactive oxygen species (ROS) generation induced by sera from IPF patients drives both collagen type I deposition and proliferation of primary human pulmonary artery smooth muscle cells (HPASMCs). IPF sera-induced cellular effects were significantly blunted in cells exposed to the NADPH oxidase inhibitor diphenyleneiodonium (DPI) proving the causative role of ROS and suggesting their potential cellular source. …”
-
14
In Vitro Cell Work of Two Types of Targeted Nanoparticles with Ultrasound Triggering
Published 2020Get full text
doctoralThesis -
15
Asynchronous MMC based parallel SA schemes for multiobjective standard cell placement
Published 2006“…Lee (1996) and applied to standard-cell placement as presented in J. Chandy et al. (1997), The schemes are applied to solve the multi-objective standard cell placement problem using an inexpensive cluster-of-workstations environment. …”
Get full text
Get full text
article -
16
The effect of 595 nm pulsed dye laser on superficial and nodular basal cell carcinomas
Published 2009“…Background and Objective Basal cell carcinomas (BCCs) have supporting vasculature that could serve as a target for 595 nm pulsed dye laser (PDL). …”
Get full text
Get full text
Get full text
Get full text
article -
17
Single-cell protein production from purple non-sulphur bacteria-based wastewater treatment
Published 2022“…<p>Large-scale production of single-cell protein (SCP) has the potential not only to solve some of the food insecurity and water scarcity crises that plague a significant portion of our world today but also holds the promise to reduce the cost associated with the treatment of industrial and agricultural wastewater. …”
-
18
Immune Checkpoints in Circulating and Tumor-Infiltrating CD4+ T Cell Subsets in Colorectal Cancer Patients
Published 2019“…We found a significant increase in the levels of CD4<sup>+</sup>FoxP3<sup>+</sup>Helios<sup>+</sup> T cells, which represent potentially highly immunosuppressive Tregs, in the CRC TME. …”
-
19
Modulation of Human Valve Interstitial Cell Phenotype and Function Using a Fibroblast Growth Factor 2 Formulation
Published 2015“…VICs in DMEM exhibited large, spread cells whereas VICs in fibroblast media were smaller, elongated and spindly. …”
-
20
The cross-talk between miRNAs and JAK/STAT pathway in cutaneous T cell lymphoma: Emphasis on therapeutic opportunities
Published 2024“…However, in recent years, progress in CTCL classification combined with next-generation sequencing analyses has broadened the genetic and epigenetic spectrum of clearly defined CTCL entities such as MF and SS. Several large-scale genome studies have identified the polygenic nature of CTCL and unveiled an idiosyncratic mutational landscape involving genetic aberrations, epigenetic alterations, cell cycle dysregulation, apoptosis, and the constitutive activation of T cell/NF-κB/JAK-STAT signaling pathways. …”